CorNova Receives $3,000,000 New Funding Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    21 A Street Burlington, MA 01803
  • Company Description
    CorNova® is a developer of next-generation endovascular products designed to integrate new technologies into existing products and procedures, resulting in better patient outcomes without added procedure time and patient risk. The FiberHalo™ stent deployment catheter will enable the physician to deploy a stent and measure in-stent lumen area during the procedure. The FiberHalo™ post-dilatation catheter will enable the physician to correct for any under-expansion and also measure post-dilatation results. CorNova is also developing a pre-dilatation version of the FiberHalo™, which will enable the physician to determine likelihood of mechanical failure of stent deployment, allowing for better decision making. CorNova has recently received CE certification on the Valecor Platinum™ stent (a bare metal stent with a pure platinum surface for increased biocompatibility and designed to reduce arterial injury), which has shown superior performance and anti-restenosis properties compared to curre
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor

Trending on Xconomy